INHALATION CHARACTERISTICS WITH SPIROMAX® AND TURBUHALER® DRY POWDER INHALERS (DPI) IN HEALTHY ADULTS AND PATIENTS WITH ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): BEFORE AND AFTER ENHANCED TRAINING

被引：2
|
作者：
Chrystyn, H. [1 ]
Azouz, W. [1 ]
Chetcuti, P. [2 ]
Hosker, H. [3 ]
Saralaya, D. [4 ]
机构：
[1] Univ Huddersfield, Huddersfield HD1 3DH, W Yorkshire, England
[2] Leeds Gen Infirm, Leeds, W Yorkshire, England
[3] Airedale Dist Gen Hosp, Bradford, W Yorkshire, England
[4] Bradford Royal Infirm, Bradford BD9 6RJ, W Yorkshire, England
来源：
THORAX | 2013年 / 68卷
关键词：
D O I：
10.1136/thoraxjnl-2013-204457.378
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：A178 / A179
页数：2
相关论文
共 50 条
  • [21] Comment and reply on: A randomized crossover trial investigating the ease of use and preference of two dry powder inhalers in patients with asthma of chronic obstructive pulmonary disease
    Macheras, Panos
    EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (05) : 823 - 824
  • [22] A randomised cross-over trial investigating the ease of use and preference of two dry powder inhalers in patients with asthma or chronic obstructive pulmonary disease
    van der Palen, Job
    van der Valk, Paul
    Goosens, Martijn
    Groothuis-Oudshoorn, Karin
    Brusse-Keizer, Marjolein
    EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (09) : 1171 - 1178
  • [23] Handgrip Evaluation Before and After Pulmonary Rehabilitation Therapy in Patients With Chronic Obstructive Pulmonary Disease (COPD)
    Posada, Nestor A. Diaz
    Rosales, Diana J. Cano
    Munoz, Maria C. Amaya
    Gomez, Mario A. Buitrago
    Villabona, Silvia J.
    Lopez, Paul Anthony Camacho
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [24] Wixela® Inhub® Dry Powder Inhaler - In Vitro Performance Compared with Advair Diskus and Inhalation Profiles in Patients with Asthma or Chronic Obstructive Pulmonary Disease
    Cooper, A.
    Newcomb, C.
    Wallace, R.
    Canham, K.
    Ward, J.
    Allan, R.
    Berry, M.
    Parker, J.
    Clift, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [25] Wixela™ Inhub™ dry powder inhaler: In vitro performance compared with Advair Diskus® and inhalation profiles in patients with asthma or chronic obstructive pulmonary disease
    Cooper, Andrew
    Newcomb, Claire
    Ward, Jonathan K.
    Allan, Richard
    Wallace, Roisin
    ALLERGY AND ASTHMA PROCEEDINGS, 2019, 40 (05) : 360 - 360
  • [26] Personalized treatment through a Dry Powder inhaler device (DPI), adjustable to Chronic Obstructive Pulmonary Disease (COPD) patient′s respiratory profile
    Zarogoulidis, Konstantinos
    Michailidis, Nikolaos
    Siopi, Dimitra
    Tsiouda, Theodora
    Theodoridou, Anatoli
    Koltsida, Ourania
    Rapti, Aggeliki
    Petridis, Dimitrios
    Porpodis, Konstantinos
    Babalis, Georgios
    Petanidis, Savvas
    Chloros, Diamantis
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [27] THE POTENTIAL FOR IMPROVED INHALATION TECHNIQUE WITH DUORESP® SPIROMAX® (BUDESONIDE plus FORMOTEROL FUMARATE DIHYDRATE) COMPARED WITH COMONLY PRESCRIBED DRY POWDER INHALERS FOR THE MANAGEMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN: ESTIMATED IMPACT ON NUMBER AND COST OF UNSCHEDULED HEALTHCARE EVENTS
    Lewis, A.
    Blackney, M.
    Garcia Bujalance, L.
    Sanchez-de la Rosa, R.
    Torvinen, S.
    Plich, A.
    VALUE IN HEALTH, 2015, 18 (07) : A350 - A350
  • [28] Knowledge and practice of dry powder inhalation among patients with chronic obstructive pulmonary disease in a regional hospital, Nepal
    Baral, Mira Adhikari
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2019, 12 : 31 - 37
  • [29] THE POTENTIAL SOCIETAL COST BENEFITS OF IMPROVED INHALATION TECHNIQUE WITH DUORESP® SPIROMAX® (BUDESONIDE plus FORMOTEROL FUMARATE DIHYDRATE) COMPARED WITH SYMBICORT® TURBUHALER® FOR THE MANAGEMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SWEDEN
    Lewis, A.
    Blackney, M.
    Torvinen, S.
    Lindqvist, F.
    Safioti, G.
    Grundström, J.
    Polyzoi, M.
    Plich, A.
    VALUE IN HEALTH, 2014, 17 (07) : A598 - A599
  • [30] Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler
    Prime, David
    de Backer, Wilfried
    Hamilton, Melanie
    Cahn, Anthony
    Preece, Andrew
    Kelleher, Dennis
    Baines, Amanda
    Moore, Alison
    Brealey, Noushin
    Moynihan, Jackie
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2015, 28 (06) : 486 - 497
12345